Do Amyloid Trajectories Reach a Physiologic Ceiling? Evidence from Iterative Approximation and Simulation
Gantenberg, J. R.; La Joie, R.; Heston, M. B.; Ackley, S. F.
Show abstract
Qualitative models of Alzheimers pathology often posit that amyloid accumulation follows a sigmoid curve, indicating that the rate of deposition wanes over time. Longitudinal PET data now allow us to investigate amyloid accumulation trajectories with greater detail and over longer follow-up periods. We combine inferences from simulated amyloid trajectories, empirical PET data from the Alzheimers Disease Neuroimaging Initiative (ADNI), and the sampled iterative local approximation algorithm (SILA) to assess whether amyloid accumulation reaches a physiologic ceiling. We find that SILA reliably detects a ceiling, when present, across a range of simulated scenarios that impose a sigmoid shape. When fit to empirical data from ADNI, however, SILA does not appear to indicate the presence of a ceiling. Thus, we conclude that amyloid trajectories may not reach a physiologic ceiling during the stages of Alzheimers disease typically observed while patients remain under follow-up in cohort studies. Fits using SILA indicate that illustrative models of biomarker cascades, while useful tools for conceptualizing and interrogating pathologic processes, may not represent the shapes of amyloid trajectories accurately. Summary for General PublicAmyloid, a protein implicated in Alzheimers disease, is thought to reach a plateau in the brain, but methods that estimate how amyloid changes over time suggest it grows unabated. Gantenberg et al. use one such method and simulations to argue that amyloid does not reach a plateau during the typical course of Alzheimers.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Association between allostatic load and accelerated white matter brain aging: findings from the UK Biobank 89%
- A Hierarchical Approach Using Marginal Summary Statistics for Multiple Intermediates in a Mendelian Randomization or Transcriptome Analysis 85%
- Comparative evaluation of methodologies for estimating the effectiveness of non-pharmaceutical interventions in the context of COVID-19: a simulation study 85%
Similar papers in this journal
- Multi-method investigation of factors influencing amyloid onset and impairment in three cohorts 96%
- Development and validation of a deep learning framework for Alzheimers disease classification 95%
- Tau-first subtype of Alzheimer's disease consistently identified across in vivo and post mortem studies 95%
Similar papers in this journal
- AI-driven fusion of neurological work-up for assessment of biological Alzheimer’s disease 95%
- Amyloid-associated increases in soluble tau is a key driver in accumulation of tau aggregates and cognitive decline in early Alzheimer 94%
- Hemispheric Asymmetry of Tau Pathology is Related to Asymmetric Amyloid Deposition in Alzheimer's Disease 93%
Similar papers in this journal
- Interpretable deep learning approach for extracting cognitive features from hand-drawn images of intersecting pentagons in older adults 92%
- A scoping review of remote and unsupervised digital cognitive assessments in preclinical Alzheimer’s disease 90%
- Machine Learning Prediction of Incidence of Alzheimers Disease Using Large-Scale Administrative Health Data 90%